Recent advances in fibrosis assessment for metabolic dysfunction-associated fatty liver disease

被引：1
|
作者：
Jeffrey, Angus W. [1 ]
Adams, Leon A. [1 ,2 ]
机构：
[1] Sir Charles Gairdner Hosp, Dept Hepatol, Nedlands, WA, Australia
[2] Univ Western Australia, Med Sch, M503,QEII Med Campus,Verdun St, Nedlands, WA 6009, Australia
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 58卷 / 06期
关键词：
artificial intelligence; fatty liver; fibrosis quantification;
D O I：
10.1111/apt.17651
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：636 / 637
页数：2
相关论文
共 50 条
  • [31] Risk of the Development of Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Rheumatoid Arthritis
    Aydin, Murat
    Aksakal, Berrin
    Basat, Sema
    [J]. ISTANBUL MEDICAL JOURNAL, 2023, 24 (04): : 357 - 363
  • [32] Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction-associated fatty liver disease in Korea
    Kim, Mimi
    Yoon, Eileen L.
    Cho, Seon
    Lee, Chul-min
    Kang, Bo-Kyeong
    Park, Huiyul
    Jun, Dae Won
    Nah, Eun-Hee
    [J]. LIVER INTERNATIONAL, 2022, 42 (07) : 1536 - 1544
  • [33] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    Han, A. Lum
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [34] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    A Lum Han
    [J]. Diabetology & Metabolic Syndrome, 14
  • [35] Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
    Lu, Chuan
    Chen, Yan
    Zhang, Yue
    Zhao, Xin
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 2627 - 2637
  • [36] Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
    Lim, Soo
    Kim, Jin-Wook
    Targher, Giovanni
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2021, 32 (07): : 500 - 514
  • [37] Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
    Lee, Chi-Ho
    Lui, David Tak-Wai
    Li, Raymond Hang-Wun
    Yuen, Michele Mae-Ann
    Fong, Carol Ho-Yi
    Leung, Ambrose Pak-Wah
    Chu, Justin Chiu-Man
    Mak, Loey Lung-Yi
    Lam, Tai-Hing
    Woo, Jean
    Woo, Yu-Cho
    Xu, Aimin
    Tse, Hung-Fat
    Tan, Kathryn Choon-Beng
    Cheung, Bernard Man-Yung
    Yuen, Man-Fung
    Lam, Karen Siu-Ling
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 13
  • [38] ASSOCIATION OF THE METABOLIC STATUS WITH THE PRESENCE OF ADVANCED LIVER FIBROSIS IN MEXICAN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)
    Mendez-Guerrero, Osvely
    Cervera, Luis A. Chi
    Reyes, Raul Bernal
    Remes-Troche, Jose Maria
    Parra, Bryan Adrian Priego
    Vazquez, Sophia E. Martinez
    Amieva-Balmori, Mercedes
    Rodriguez, Leonardo A. Martinez
    Triana-Romero, Arturo
    Chavez, Maria E. Icaza
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S673 - S673
  • [39] Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
    Chen, Jiaxin
    Jian, Linge
    Guo, Yangkun
    Tang, Chengwei
    Huang, Zhiyin
    Gao, Jinhang
    [J]. ANTIOXIDANTS, 2024, 13 (06)
  • [40] Are dairy products the answer to metabolic dysfunction-associated fatty liver disease?
    Lau, Kristopher Cho-Hei
    Wong, Vincent Wai-Sun
    [J]. HEPATOLOGY INTERNATIONAL, 2024, 18 (03) : 870 - 872
12345